Elevated circulating alpha-klotho by angiotensin II receptor blocker losartan is associated with reduction of albuminuria in type 2 diabetic patients
Introduction: The aging-suppression gene α-klotho is potentially reno-protective. Animal studies suggest that angiotensin II may be a negative regulator of α-klotho expression. Therefore, we hypothesize that renin–angiotensin system antagonism may increase α-klotho secretion in type 2 diabetes (T2DM...
Main Authors: | Su Chi Lim, Jian-Jun Liu, Tavintharan Subramaniam, Chee Fang Sum |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi - SAGE Publishing
2014-12-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.1177/1470320313475905 |
Similar Items
-
The use of angiotensin receptor blocker losartan in the combinational therapy of arterial hypertension
by: N Sh Zagidullin, et al.
Published: (2009-12-01) -
Angiotensin receptor blockers in nephroprotection at patients with diabetes mellitus: focus on losartan
by: Ol'ga Konstantinovna Vikulova, et al.
Published: (2009-09-01) -
Effects of adding tripterygium glycosides to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on albuminuria in patients with diabetic nephropathy
by: Jin-Ying Fang, et al.
Published: (2020-03-01) -
Dissociation between the circulating renin-angiotensin system and angiotensin II receptors in central losartan-induced hypertension
by: A.M. Sugawara, et al.
Published: (2002-09-01) -
The Decrement of Hemoglobin Concentration with Angiotensin II Receptor Blocker Treatment Is Correlated with the Reduction of Albuminuria in Non-Diabetic Hypertensive Patients: Post-Hoc Analysis of ESPECIAL Trial.
by: Jung Nam An, et al.
Published: (2015-01-01)